G01N 2333/545
Il-1
G01N2333/545 (Il-1) appears on 109 US grants and 262 published applications in this corpus.
Search patents in G01N- Granted patents
- 109
- Published applications
- 262
- Assignees
- 145
- Inventors
- 491
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 5 |
| 2004 | 0 | 2 |
| 2005 | 2 | 6 |
| 2006 | 1 | 1 |
| 2007 | 1 | 3 |
| 2008 | 1 | 6 |
| 2009 | 0 | 7 |
| 2010 | 2 | 5 |
| 2011 | 3 | 14 |
| 2012 | 2 | 14 |
| 2013 | 5 | 13 |
| 2014 | 10 | 20 |
| 2015 | 8 | 21 |
| 2016 | 9 | 21 |
| 2017 | 12 | 12 |
| 2018 | 12 | 14 |
| 2019 | 8 | 7 |
| 2020 | 8 | 12 |
| 2021 | 4 | 10 |
| 2022 | 4 | 9 |
| 2023 | 0 | 21 |
| 2024 | 5 | 13 |
| 2025 | 6 | 14 |
| 2026 | 2 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cytokine-based therapies and methods30 Jun 2026US 12,668,627 B2Reverb Therapeutics, Inc.
- Method for measuring systemic chronic inflammaging6 Jan 2026US 12,517,135 B2Edifice Health, Inc.
- Biomarker panels for on-treatment prediction of response to immuno-oncology drugs30 Sep 2025US 12,429,485 B2The Brigham and Women S Hospital, Inc.
- System for detecting infection in synovial fluid12 Aug 2025US 12,385,909 B2CD Diagnostics, Inc.
- Systems and methods for MHC class II epitope prediction29 Jul 2025US 12,374,423 B2The Broad Institute, Inc.
- Methods of treating endometriosis1 Oct 2026US 2026/0298926 A1Cedars-Sinai Medical Center
- Methods of treating alzheimer's disease17 Sep 2026US 2026/0274931 A1Klaritos, Inc.
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
- Humoral Immune Activators for the Treatment of Humoral Immunosuppressed Pathologies, Cancer and Infectious Disease and Humoral Immune Suppressors for the Treatment of Inflammatory Diseases3 Sep 2026US 2026/0256811 A1Navrogen, Inc.
- Methods of predicting and treating immunotherapy adverse events based on immune cell populations16 Jul 2026US 2026/0202406 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Methods and apparatus for conducting multiple measurements on a sample125US 7,858,321 B2Meso Scale Technologies, LLC. · 2010
- Prostaglandin E2 dual variable domain immunoglobulins and uses thereof85US 8,822,645 B2AbbVie Inc. · 2014
- Dual variable domain immunoglobulins and uses thereof65US 8,735,546 B2AbbVie Inc. · 2014
- Dual variable domain immunoglobulins and uses thereof41US 9,035,027 B2AbbVie Inc. · 2015